Cargando…

Non-pharmaceutical interventions to optimize cancer immunotherapy

The traditional picture of cancer patients as weak individuals requiring maximum rest and protection is beginning to dissolve. Too much focus on the medical side and one’s own vulnerability and mortality might be counterproductive and not doing justice to the complexity of human nature. Unlike cytot...

Descripción completa

Detalles Bibliográficos
Autores principales: Boesch, Maximilian, Baty, Florent, Rassouli, Frank, Kowatsch, Tobias, Joerger, Markus, Früh, Martin, Brutsche, Martin H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543347/
https://www.ncbi.nlm.nih.gov/pubmed/37791231
http://dx.doi.org/10.1080/2162402X.2023.2255459
_version_ 1785114282431610880
author Boesch, Maximilian
Baty, Florent
Rassouli, Frank
Kowatsch, Tobias
Joerger, Markus
Früh, Martin
Brutsche, Martin H.
author_facet Boesch, Maximilian
Baty, Florent
Rassouli, Frank
Kowatsch, Tobias
Joerger, Markus
Früh, Martin
Brutsche, Martin H.
author_sort Boesch, Maximilian
collection PubMed
description The traditional picture of cancer patients as weak individuals requiring maximum rest and protection is beginning to dissolve. Too much focus on the medical side and one’s own vulnerability and mortality might be counterproductive and not doing justice to the complexity of human nature. Unlike cytotoxic and lympho-depleting treatments, immune-engaging therapies strengthen the immune system and are typically less harmful for patients. Thus, cancer patients receiving checkpoint inhibitors are not viewed as being vulnerable per se, at least not in immunological and physical terms. This perspective article advocates a holistic approach to cancer immunotherapy, with an empowered patient in the center, focusing on personal resources and receiving domain-specific support from healthcare professionals. It summarizes recent evidence on non-pharmaceutical interventions to enhance the efficacy of immune checkpoint blockade and improve quality of life. These interventions target behavioral factors such as diet, physical activity, stress management, circadian timing of checkpoint inhibitor infusion, and waiving unnecessary co-medication curtailing immunotherapy efficacy. Non-pharmaceutical interventions are universally accessible, broadly applicable, instantly actionable, scalable, and economically sustainable, creating value for all stakeholders involved. Most importantly, this holistic framework re-emphasizes the patient as a whole and harnesses the full potential of anticancer immunity and checkpoint blockade, potentially leading to survival benefits. Digital therapeutics are proposed to accompany the patients on their mission toward change in lifestyle-related behaviors for creating optimal conditions for treatment efficacy and personal growth.
format Online
Article
Text
id pubmed-10543347
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-105433472023-10-03 Non-pharmaceutical interventions to optimize cancer immunotherapy Boesch, Maximilian Baty, Florent Rassouli, Frank Kowatsch, Tobias Joerger, Markus Früh, Martin Brutsche, Martin H. Oncoimmunology Review The traditional picture of cancer patients as weak individuals requiring maximum rest and protection is beginning to dissolve. Too much focus on the medical side and one’s own vulnerability and mortality might be counterproductive and not doing justice to the complexity of human nature. Unlike cytotoxic and lympho-depleting treatments, immune-engaging therapies strengthen the immune system and are typically less harmful for patients. Thus, cancer patients receiving checkpoint inhibitors are not viewed as being vulnerable per se, at least not in immunological and physical terms. This perspective article advocates a holistic approach to cancer immunotherapy, with an empowered patient in the center, focusing on personal resources and receiving domain-specific support from healthcare professionals. It summarizes recent evidence on non-pharmaceutical interventions to enhance the efficacy of immune checkpoint blockade and improve quality of life. These interventions target behavioral factors such as diet, physical activity, stress management, circadian timing of checkpoint inhibitor infusion, and waiving unnecessary co-medication curtailing immunotherapy efficacy. Non-pharmaceutical interventions are universally accessible, broadly applicable, instantly actionable, scalable, and economically sustainable, creating value for all stakeholders involved. Most importantly, this holistic framework re-emphasizes the patient as a whole and harnesses the full potential of anticancer immunity and checkpoint blockade, potentially leading to survival benefits. Digital therapeutics are proposed to accompany the patients on their mission toward change in lifestyle-related behaviors for creating optimal conditions for treatment efficacy and personal growth. Taylor & Francis 2023-09-28 /pmc/articles/PMC10543347/ /pubmed/37791231 http://dx.doi.org/10.1080/2162402X.2023.2255459 Text en © 2023 The Author(s). Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.
spellingShingle Review
Boesch, Maximilian
Baty, Florent
Rassouli, Frank
Kowatsch, Tobias
Joerger, Markus
Früh, Martin
Brutsche, Martin H.
Non-pharmaceutical interventions to optimize cancer immunotherapy
title Non-pharmaceutical interventions to optimize cancer immunotherapy
title_full Non-pharmaceutical interventions to optimize cancer immunotherapy
title_fullStr Non-pharmaceutical interventions to optimize cancer immunotherapy
title_full_unstemmed Non-pharmaceutical interventions to optimize cancer immunotherapy
title_short Non-pharmaceutical interventions to optimize cancer immunotherapy
title_sort non-pharmaceutical interventions to optimize cancer immunotherapy
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543347/
https://www.ncbi.nlm.nih.gov/pubmed/37791231
http://dx.doi.org/10.1080/2162402X.2023.2255459
work_keys_str_mv AT boeschmaximilian nonpharmaceuticalinterventionstooptimizecancerimmunotherapy
AT batyflorent nonpharmaceuticalinterventionstooptimizecancerimmunotherapy
AT rassoulifrank nonpharmaceuticalinterventionstooptimizecancerimmunotherapy
AT kowatschtobias nonpharmaceuticalinterventionstooptimizecancerimmunotherapy
AT joergermarkus nonpharmaceuticalinterventionstooptimizecancerimmunotherapy
AT fruhmartin nonpharmaceuticalinterventionstooptimizecancerimmunotherapy
AT brutschemartinh nonpharmaceuticalinterventionstooptimizecancerimmunotherapy